Company: NGVT
Filing Date: 2025-02-25
Form Type: DEFA14A
Source: 0001140361-25-005894
Chunk: 9

Company: Ingevity Corp
Filing Date: 2025-02-25
Form: DEFA14A
Chunk 9
---
 Forms 4 filed by Mary Dean Hall on April 23, 2024and February 21, 2025; Form 4 filed by Steve Hulme on February 21, 2025; Form 4 filed by Ed Woodcock on February 21, 2025; Form 4 filed by Benjamin (Shon) Wright on April 26, 2024; Form 4 filed by Dan Sansone on April 26, 2024; Form 4 filed by Karen Narwold on April 26, 2024; Form 4 filed by Fred Lynch on April 26, 2024; Form 4 filed by Bruce Hoechner on April 26, 2024; Form 4 filed by Diane Gulyas on April 26, 2024; Form 4 filed by Jean Blackwell on April 26, 2024; Forms 4 filed by Rich White on July 3, 2024and February 21, 2025; Form 3 filed by Ryan Fisher on April 8, 2024and Forms 4 filed by Ryan Fisher on May 7, 2024, July 8, 2024and February 21, 2025; Forms 4 filed by Phillip Platt on August 13, 2024and February 21, 2025; Form 3 filed by Terry Dyer on August 13, 2024; Forms 4 filed by Luis Fernandez-Moreno on April 26, 2024and October 4, 2024; and Form 3 filed by Kevin Willis on December 19, 2024and Forms 4 filed by Kevin Willis on December 19, 2024and January 3, 2025. Additional information can also be found in Ingevity’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 19, 2025. Details concerning the nominees of Ingevity’s Board of Directors for election at the 2025 Annual Meeting will be included in the Proxy Statement. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, INCLUDING INGEVITY’S PROXY STATEMENT WHEN IT BECOMES AVAILABLE (AND ANY AMENDMENTS AND SUPPLEMENTS THERETO) CAREFULLY